Latanoprost in hemifacial spasm

An empirical observation that the prostaglandin derivate latanoprost quited facial spasms in patients with glaucoma prompted us to study latanoprost in non-glaucomatous patients with hemifacial spasms [HFS]. This explorative trial followed an open-label, prospective treatment design. At short term,...

Full description

Saved in:
Bibliographic Details
Published inProstaglandins & other lipid mediators Vol. 67; no. 1; pp. 27 - 30
Main Authors Crevits, Luc, Goethals, Maarten, Libbrecht, Niels, Paemeleire, Koen
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 2002
Subjects
Aged
Female
Glaucoma - complications
Glaucoma - drug therapy
Hemifacial Spasm - drug therapy
Hemifacial spasms
Humans
Latanoprost
Male
Middle Aged
Prospective Studies
Prostaglandin
Prostaglandins F, Synthetic - therapeutic use
Therapy
Treatment Outcome
Trial
Therapy
Trial
Prostaglandin
Hemifacial spasms
Latanoprost
Online AccessGet full text

Cover

More Information
Summary:An empirical observation that the prostaglandin derivate latanoprost quited facial spasms in patients with glaucoma prompted us to study latanoprost in non-glaucomatous patients with hemifacial spasms [HFS]. This explorative trial followed an open-label, prospective treatment design. At short term, most patients showed no or only mild improvement and subsequently needed therapy with Botulinum toxin A. Although these results are not impressive, latanoprost could be considered as an interesting alternative in the treatment of patients with HFS and with concomitant glaucoma. A role for prostaglandins in the trigeminofacial reflex is hypothesised.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1098-8823
DOI:10.1016/S0090-6980(01)00168-X